Showing results (2181-2190 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|April 13, 2002
A Monte Carlo simulation for modelling outcomes of AIDS treatment regimensAnke Richter, Brett Hauber, Kit Simpson, et al.Pharmacoeconomics|January 30, 2010
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessationGillian M Keating, Katherine A Lyseng-WilliamsonPharmacoeconomics|November 14, 2009
Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UKJeroen P Jansen, Ritesh Kumar, Yehuda CarmeliPharmacoeconomics|November 10, 2005
Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levelsMarieke E van Velden, Johan L Severens, Annoesjka NovakPharmacoeconomics|September 26, 2018
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in KoreaYun-Kyung Kim, Joon Young Song, Hyeongap Jang, et al.Pharmacoeconomics|September 18, 2018
Systematic Literature Review of the Economic Burden of Celiac DiseaseElizabeth S Mearns, Aliki Taylor, Talia Boulanger, et al.Pharmacoeconomics|June 29, 2018
Ibrutinib for Treating Waldenström's Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPaul Tappenden, Christopher Carroll, John Stevens, et al.Pharmacoeconomics|October 10, 2018
The Monetary Value of Informal Care: Obtaining Pure Time Valuations Using a Discrete Choice ExperimentRenske J Hoefman, Job van Exel, Werner B F BrouwerPharmacoeconomics|July 5, 2017
Discrete Event Simulation-Based Resource Modelling in Health Technology AssessmentSyed Salleh, Praveen Thokala, Alan Brennan, et al.Pharmacoeconomics|May 6, 2017
Evaluation of Healthcare Interventions and Big Data: Review of Associated Data IssuesCarl V Asche, Brian Seal, Kristijan H Kahler, et al.Pageof 336